Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
antibodies, Biological, ALL, AML, apoptosis, Leukemia, Non-Biological, CLL, Diseases, drug-drug interaction, Lymphoma (any), CAR-Ts, Combinations, Therapies, Hodgkin Lymphoma, Mantle Cell Lymphoma, chemotherapy, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Biological Processes, DNA damage, Technology and Procedures, immunotherapy, Lymphoid Malignancies, Clinically relevant, Myeloid Malignancies, pharmacology, Quality Improvement , TKI, integrative -omics, molecular testing, metabolomics, molecular interactions, pathways, proteomics, signal transduction
	Type: Oral
Hematology Disease Topics & Pathways:
antibodies, Biological, ALL, AML, apoptosis, Leukemia, Non-Biological, CLL, Diseases, drug-drug interaction, Lymphoma (any), CAR-Ts, Combinations, Therapies, Hodgkin Lymphoma, Mantle Cell Lymphoma, chemotherapy, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Biological Processes, DNA damage, Technology and Procedures, immunotherapy, Lymphoid Malignancies, Clinically relevant, Myeloid Malignancies, pharmacology, Quality Improvement , TKI, integrative -omics, molecular testing, metabolomics, molecular interactions, pathways, proteomics, signal transduction
Monday, December 7, 2020: 7:00 AM-8:30 AM
	
	
	
	
	   
			
		Moderators:
			
				
				
					
						
						
						
							Scott F. Huntington, MD, MPH, Yale University School of Medicine
						
					
					
				
					
						 and 
						
						
							Nicolas Nassar, PhD, Cincinnati Children Hospital Medical Center
						
					
					
				
			
 
			
			Disclosures:
			
			
				
			
				
			
			Huntington: AbbVie: Consultancy; Astrazeneca: Honoraria; Bayer: Consultancy, Honoraria; Celgene: Consultancy, Research Funding; DTRM: Research Funding; Genentech: Consultancy; Novartis: Consultancy; Pharmacyclics: Honoraria; TG Therapeutics: Research Funding; Flatiron Health: Consultancy; BeiGene: Consultancy. 
			 
		7:00 AM
	
	
7:15 AM
	
	
7:30 AM
	
	
7:45 AM
	
	
8:00 AM
	
	
8:15 AM
	
	
	
	
	See more of: Oral and Poster Abstracts
	
	
	
	
	*signifies non-member of ASH
					
 denotes an abstract that is clinically relevant.
 denotes that this is a recommended PHD Trainee Session.